The SPORE in Lung Cancer
At Vanderbilt-Ingram Cancer Center, three NCI SPORE grants support research in lung, breast and GI cancers. The SPORE in Lung Cancer is one of only six in the country, and recently received a new round of support from the NCI with a five-year, $12 million grant that focuses on innovative, translational research to reduce death and suffering due to lung cancer and ultimately prevent the disease.
Pilot Project Grants for SPORE in Lung Cancer Renewal
The Thoracic Program of the Vanderbilt-Ingram Cancer Center is pleased to announce the availability of pilot project grants for the conduct of basic, translational, or clinical research on the cause, prevention, detection, control, or treatment of lung cancer. Funds are available to support projects from individual investigators or collaborative teams. Original cancer-related projects with the potential to develop into independent R01 grants are encouraged. Grants from $25,000 to $50,000 in total costs will be awarded for a one-year period. All grants will be evaluated by peer review and will be funded by December 1, 2012.
The deadline for submission is November 9, 2012
Information and application guidelines may be obtained from Jennifer Whitsitt in the VICC Administrative Office (691 Preston Building; telephone: 936-1279 or email: email@example.com).